Borko Amulic
Max Planck Society
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Borko Amulic.
Journal of Experimental Medicine | 2013
Matthias F. Muellenbeck; Beatrix Ueberheide; Borko Amulic; Alexandra Epp; David Fenyö; Christian E. Busse; Meral Esen; Michael Theisen; Benjamin Mordmüller; Hedda Wardemann
Plasmodium falciparum infection leads to the development of protective classical and atypical memory B cell antibody responses.
Blood | 2015
Christopher J. Harbort; Paulo Vítor Soeiro-Pereira; Horst von Bernuth; Angela M. Kaindl; Beatriz Tavares Costa-Carvalho; Antonio Condino-Neto; Janine Reichenbach; Joachim Roesler; Arturo Zychlinsky; Borko Amulic
Neutrophils play an essential role in the initial stages of inflammation by balancing pro- and antiinflammatory signals. Among these signals are the production of proinflammatory cytokines and the timely initiation of antiinflammatory cell death via constitutive apoptosis. Here we identify ataxia-telangiectasia mutated (ATM) kinase as a modulator of these neutrophil functions. Ataxia-telangiectasia (AT) is a pleiotropic multisystem disorder caused by mutations in the gene-encoding ATM, a master regulator of the DNA damage response. In addition to progressive neurodegeneration and high rates of cancer, AT patients have numerous symptoms that can be linked to chronic inflammation. We report that neutrophils isolated from patients with AT overproduce proinflammatory cytokines and have a prolonged lifespan compared with healthy controls. This effect is partly mediated by increases in activation of p38 MAP kinase. Furthermore, we show that the oxidative burst, catalyzed by nicotinamide adenine dinucleotide phosphate oxidase, can activate ATM in neutrophils. Finally, activation of ATM and DNA damage signaling suppress cytokine production and can abrogate the overproduction of IL-8 in ROS-deficient cells. This reveals a novel mechanism for the regulation of cytokine production and apoptosis, establishing DNA damage as a downstream mediator of immune regulation by reactive oxygen species. We propose that deficiencies in the DNA damage response, like deficiencies in the oxidative burst seen in chronic granulomatous disease, could lead to pathologic inflammation.
Antimicrobial Agents and Chemotherapy | 2013
Christof Sparr; Nirupam Purkayastha; Beata Kolesinska; Martin Gengenbacher; Borko Amulic; Dieter Seebach; Faustin Kamena
ABSTRACT Cellular drug delivery can improve efficacy and render intracellular pathogens susceptible to compounds that cannot permeate cells. The transport of physiologically active compounds across membranes into target cells can be facilitated by cell-penetrating peptides (CPPs), such as oligoarginines. Here, we investigated whether intracellular delivery of the drug fosmidomycin can be improved by combination with the CPP octaarginine. Fosmidomycin is an antibiotic that inhibits the second reaction in the nonmevalonate pathway of isoprenoid biosynthesis, an essential pathway for many obligate intracellular pathogens, including mycobacteria and apicomplexan parasites. We observed a strict correlation between octaarginine host cell permeability and its ability to improve the efficacy of fosmidomycin. Plasmodium berghei liver-stage parasites were only partially susceptible to an octaarginine-fosmidomycin complex. Similarly, Toxoplasma gondii was only susceptible during the brief extracellular stages. In marked contrast, a salt complex of octaarginine and fosmidomycin greatly enhanced efficacy against blood-stage Plasmodium falciparum. This complex and a covalently linked conjugate of octaarginine and fosmidomycin also reverted resistance of Mycobacteria to fosmidomycin. These findings provide chemical genetic evidence for vital roles of the nonmevalonate pathway of isoprenoid biosynthesis in a number of medically relevant pathogens. Our results warrant further investigation of octaarginine as a delivery vehicle and alternative fosmidomycin formulations for malaria and tuberculosis drug development.
PLOS ONE | 2016
Gabriel Sollberger; Borko Amulic; Arturo Zychlinsky
Neutrophils are essential innate immune cells whose responses are crucial in the clearance of invading pathogens. Neutrophils can respond to infection by releasing neutrophil extracellular traps (NETs). NETs are formed of chromatin and specific granular proteins and are released after execution of a poorly characterized cell death pathway. Here, we show that NET formation induced by PMA or Candida albicans is independent of RNA polymerase II and III-mediated transcription as well as of protein synthesis. Thus, neutrophils contain all the factors required for NET formation when they emerge from the bone marrow as differentiated cells.
Developmental Cell | 2017
Borko Amulic; Sebastian Lorenz Knackstedt; Ulrike Abu Abed; Nikolaus Deigendesch; Christopher J. Harbort; Brian Caffrey; Volker Brinkmann; Frank L. Heppner; Philip W. Hinds; Arturo Zychlinsky
Neutrophils are essential for immune defense and can respond to infection by releasing chromatin in the form of neutrophil extracellular traps (NETs). Here we show that NETs are induced by mitogens and accompanied by induction of cell-cycle markers, including phosphorylation of the retinoblastoma protein and lamins, nuclear envelope breakdown, and duplication of centrosomes. We identify cyclin-dependent kinases 4 and 6 (CDK4/6) as essential regulators of NETs and show that the response is inhibited by the cell-cycle inhibitor p21Cip. CDK6, in neutrophils, is required for clearance of the fungal pathogen Candida albicans. Our data describe a function for CDK4/6 in immunity.
Orphanet Journal of Rare Diseases | 2014
Horst von Bernuth; Ethiraj Ravindran; Hang Du; Sebastian Fröhler; Karoline Strehl; Nadine Krämer; Lina Issa-Jahns; Borko Amulic; Olaf Ninnemann; Mei-Sheng Xiao; Katharina Eirich; Uwe Kölsch; Kathrin Hauptmann; Rainer John; Detlev Schindler; Volker Wahn; Wei Chen; Angela M. Kaindl
The autosomal recessive immunodeficiency-centromeric instability-facial anomalies syndrome (ICF) is characterized by immunodeficiency, developmental delay, and facial anomalies. ICF2, caused by biallelic ZBTB24 gene mutations, is acknowledged primarily as an isolated B-cell defect. Here, we extend the phenotype spectrum by describing, in particular, for the first time the development of a combined immune defect throughout the disease course as well as putative autoimmune phenomena such as granulomatous hepatitis and nephritis. We also demonstrate impaired cell-proliferation and increased cell death of immune and non-immune cells as well as data suggesting a chromosome separation defect in addition to the known chromosome condensation defect.
Annual Review of Immunology | 2012
Borko Amulic; Christel Cazalet; Garret L. Hayes; Kathleen D. Metzler; Arturo Zychlinsky
Current Biology | 2011
Borko Amulic; Garret L. Hayes
publisher | None
author
Parasite Immunology | 2017
Stéphanie Boström; Christentze Schmiegelow; U. Abu Abed; Daniel T. R. Minja; John Lusingu; Volker Brinkmann; Yabo Josiane Honkpehedji; Marguerite Massinga Loembe; Ayola A. Adegnika; Benjamin Mordmüller; Marita Troye-Blomberg; Borko Amulic